Inside the research

Sotera Health Company

SHC Research profile · latest available data

Price overview

$18.34

▼ -0.11 (-0.6%)

52w hi$19.57
52w lo$13.13
Vol1.25M
As of25 Sep 2026

The Verdict

Hold

Our score +0.48

Short+0.33
Medium+0.60
Long+0.53

computed 2026-09-27

Key fundamentals

Sotera Health Company

Healthcare · Diagnostics & Research

Market cap$5.23B
Enterprise value$7.14B
Trailing P/E32.18x
Forward P/E17.06x
EV / EBITDA12.39x
P / S (ttm)4.30x
Profit margin13.4%
Return on equity27.8%
Revenue growth+9.2%
Earnings growth+569.5%
Debt / equity340.73

Layer Breakdown

LayerRawContribution
Fundamental+0.30
Sector+0.08
Technical+0.28
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

United States · soterahealth.com

Risk Metrics

Beta vs SPX1.14
Corr SPX0.49
Annual vol37.7%
Annual ret+11.7%
Sharpe0.31
Max DD-41.8%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-08-14Officer / Director Changeread
2026-08-06Earnings Release, Exhibitsread
2026-05-22Shareholder Voteread
2026-05-20Material Agreement, Material Obligation…read
2026-05-13Termination of Agreement, Other Material Event…read
2026-05-05Earnings Release, Officer / Director Change…read
2026-03-16Officer / Director Changeread
2026-03-06Other Material Event, Exhibitsread
2026-02-24Earnings Release, Officer / Director Change…read
2026-02-05Officer / Director Changeread
2026-01-12Earnings Release, Reg FD Disclosure…read
2025-11-10Other Material Event, Exhibitsread

Flow & Concentration

Insider 180d net$0
Insider buys / sells0 / 0
Insider biasNeutral
13F holders8
Top-5 share95.6%
HHI2,478 (moderate)

Top Holders

HolderValueShares
AQR Capital Management$186.40M10.73M
State Street Corp$147.76M8.32M
Fidelity / FMR LLC$109.58M6.17M
Citadel Advisors$35.59M2.01M
Millennium Management$34.30M1.93M
Capital Research / Capital World$23.46M1.32M
Bridgewater Associates$341.53K19.24K
T. Rowe Price Group$4.64K261.40K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-08-148-Kview
2026-08-114view
2026-08-074view
2026-08-068-Kview
2026-08-0610-Qview
2026-05-274view
2026-05-274view
2026-05-274view
2026-05-274view
2026-05-274view
2026-05-274view
2026-05-274view
2026-05-273view
2026-05-274view
2026-05-274view

The Long Run

FY 2021–2025 · 5 years

LineLatestCAGRTrend
Revenue$1.05B+3.0%
Gross profit$645.53M+13.0%
Operating income$276.69M+2.5%
Net income$51.38M+0.0%
Cash from ops$224.16M-5.5%

Indices

S&P MidCap 400

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$18.44$18.58$18.21$18.341.25M
Sep 24$18.24$18.63$18.23$18.451.32M
Sep 23$18.68$18.82$18.17$18.291.76M
Sep 22$18.79$18.95$18.62$18.691.50M
Sep 21$18.81$18.94$18.52$18.702.15M

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →